GlassScriptPhysician profile
Marcia L Cave
NPI 1962401646
$9,091.25
in general payments reported to CMS, 2019-2025
46 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $644 · 2021: $1,101 · 2022: $1,097 · 2023: $1,880 · 2024: $2,062 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,045 · Travel and Lodging: $2,009 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,044.81 |
| Travel and Lodging | $2,009.30 |
| Education | $203.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $2,264.17 | 2022-2024 | Gelpoint V-Path |
| Abbvie INC. | $1,001.95 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $955.54 | 2019-2025 | Veozah, Myrbetriq |
| Ethicon US, LLC | $426.36 | 2019-2025 | Stratafix, Vistaseal, Surgicel Nu-Knit |
| Mayne Pharma Commercial LLC | $363.66 | 2021-2025 | |
| Amgen INC. | $354.48 | 2019-2024 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $338.36 | 2023-2025 | Myfembree, Gemtesa |
| Biogen, INC. | $308.65 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $285.94 | 2019-2024 | |
| Novo Nordisk INC | $267.13 | 2019-2025 | Wegovy |
| Aspira Women'S Health INC | $184.68 | 2023 | Ova1 |
| Daiichi Sankyo INC. | $166.01 | 2020-2023 | Injectafer |
| Boston Scientific Corporation | $156.09 | 2019-2024 | Advantage System, Solyx Sis System |
| Avion Pharmaceuticals | $140.25 | 2020-2022 | |
| Covidien LP | $138.41 | 2019 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Cave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.